IMFINZI 500 mg/10mL
Durvalumab · INJECTION, SOLUTION · AstraZeneca Pharmaceuticals LP
No Recall History
Plain English
IMFINZI is a injection, solution containing durvalumab at 500 mg/10mL, taken intravenous. Manufactured by AstraZeneca Pharmaceuticals LP.
Key Facts
- Brand Name
- IMFINZI
- Generic Name
- Durvalumab
- NDC Code (Product)
0310-4611- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 500 mg/10mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761069
- Drug Class
- Programmed Death Ligand-1 Blocker [EPC]
- Marketing Start
- 05/01/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is IMFINZI used for?
IMFINZI contains Durvalumab. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is IMFINZI a controlled substance?
IMFINZI is not classified as a controlled substance by the DEA.
What is the generic name for IMFINZI?
The generic name for IMFINZI is Durvalumab. There are no other listed brand versions of Durvalumab.
What is the NDC code for IMFINZI 500 mg/10mL?
The NDC (National Drug Code) for IMFINZI 500 mg/10mL is 0310-4611, listed by AstraZeneca Pharmaceuticals LP.
Other IMFINZI Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)